5
Clinical Trials associated with Moist exposed burn ointment (MEBO)Assessing the Effects and Safety of MEBO as Add on Therapy for the Prevention of Radiotherapy-Induced Mucositis
Radiation therapy (RT) is used in at least 50% of cancer patients and is critical in treating and palliating tumor-related symptoms. Normal tissue radiation toxicity remains an overwhelming obstacle in treating cancer patients with localized tumors.
Mucositis is the inflammation and ulceration of the oral and gastrointestinal mucosa observed with different cancer therapies. Oral mucositis is a common, severe, and debilitating complication of RT occurring several days to weeks after RT initiation.
Assessment of Topical Mebo Versus Lidocane in Healing Time of Traumatic Oral Ulcer: Randomized Controlled Trial
This study aims to assess topical MEBO application on pain relief and wound healing.
Comparative Evaluation of MEBO Ointment and Topical Diltiazem Ointment in the Treatment of Acute Anal Fissure: a Randomized Clinical Trial
No study to date has compared topical DTZ to MEBO ointment in the treatment of anal fissure. Therefore, the present study aims to compare the efficacy and safety of DTZ to MEBO in the treatment of acute anal fissure. The investigators propose to conduct a comparative randomized clinical study. In this study, the investigators will compare patients with acute anal fissure receiving MEBO ointment vs Topical DTZ ointment vs a combination of MEBO and DTZ ointment.
Hypothesis:
MEBO in combination with DTZ is more effective than DTZ or MEBO alone in the treatment of acute anal fissure.
100 Clinical Results associated with Moist exposed burn ointment (MEBO)
100 Translational Medicine associated with Moist exposed burn ointment (MEBO)
100 Patents (Medical) associated with Moist exposed burn ointment (MEBO)
100 Deals associated with Moist exposed burn ointment (MEBO)